Muscular dystrophy-related quantitative and chemical changes in adenohypophysis GH-cells in golden retrievers

Growth Hormone and IGF Research

Volumn 17, Issue 6, 2007, Pages 480-491

  de Lima, A R ^a   Nyengaard, J R ^b   Jorge, A A L ^c   Balieiro, J C C ^c   Peixoto, C ^c   Fioretto, E T ^a   Ambrosio C E ^c   Miglino, M A ^c   Zatz, M ^c   Ribeiro, A A C M ^a  

^a Department of Surgery   (Brazil)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Duchenne muscular dystrophy; GH; Golden retriever; Hypophysis; Stereology

Indexed keywords

DYSTROPHIN; GROWTH HORMONE; SOMATOMEDIN C;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL GRANULE; CELL SIZE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CELL VOLUME; CONTROLLED STUDY; CYTOSOL; DATA ANALYSIS; DISEASE SEVERITY; DOG; DUCHENNE MUSCULAR DYSTROPHY; GROWTH HORMONE RELEASE; HYPOPHYSIS CELL; HYPOPHYSIS PARS DISTALIS; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEREOLOGY;

ANIMALS; BODY WEIGHT; CELL COUNT; CELL SIZE; CREATINE KINASE; CYTOPLASMIC GRANULES; DISEASE PROGRESSION; DOGS; DYSTROPHIN; GENOTYPE; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCULAR DYSTROPHY, ANIMAL; PITUITARY GLAND, ANTERIOR; POLYMERASE CHAIN REACTION; REFERENCE VALUES;

EID: 35848957044     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.06.001     Document Type: Article

References (48)

1. Nguyen F., Guigand L., Goubault-Leroux I., Wyers M., and Cherel Y. Micro vessel density in muscles of dogs with golden retriever muscular dystrophy. Neuromus. Disord. 15 (2005) 154-163
2. Hoffman E.P., Brown R.H., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
3. Collins C.A., and Morgan J.E. Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int. J. Exp. Pathol. 84 (2003) 165-172
4. Childers M.K., Okamura C.S., Bogan D.J., Bogan J.R., Petroski G.F., Mcdonald K., and Kornegay J.N. Eccentric contraction injury in dystrophic canine muscle. Arch. Phys. Med. Rehabil. 83 (2002) 1572-1578
5. Bogdanovich S., Perkins K.J., Krag T.O.B., and Khurana T.S. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J. Mol. Med. 82 (2004) 102-115
6. Emery A.H. Population frequencies of inherited neuromuscular diseases-a world survey. Neur. Disord. 1 (1991) 19-29
7. Zatz M., Betti R.T.B., and Levy J.A. Benign duchenne muscular dystrophy in a patient with growth hormone deficiency. Am. J. Med. Genet. 10 (1981) 301-304
8. Frank G.R., and Smith R.E. Effective growth hormone theraphy in a growth hormone deficient patient with Duchenne muscular dystrophy without evidence of acceleration of the dystrophic process. J. Pediatr. Endocr. Metabol. 14 (2001) 211-214
9. Ghafoor T., Mahmood A., and Shams S. Duchenne muscular dystrophy with associated growth hormone deficiency. J. Coll. Physic. Surg. Pak. 13 (2003) 722-723
10. Kurtenbach E., Moraes S.S., Trocado M.T., Lobo G.F., Nascimento P.S., and Verjovski-Almeida S. Beneficial effects of anti-growth hormone antiserum in avian muscular dystrophy. FASEB J. 3 (1989) 2189-2193
11. Shelton G.D., Liu L.A., Guo L.T., Smith G., Christiansen J.S., Thomas W.B., Smith M.O., Kline K.L., March P.A., Flegel T., and Engvall E. Muscular dystrophy in female dogs. J. Vet. Int. Med. 15 (2001) 240-244
12. Bergman R.L., Inzana K.D., Monroe W.E., Shell L.G., Liu L.A., Engvall E., and Shelton G.D. Dystrophin-deficient muscular dystrophy in a Labrador Retriever. J. Am. Hosp. Assoc. 38 (2002) 255-261
13. Blake D.J., Weir A., Newey S.E., and Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82 (2002) 291-329
14. Ehmsen J., Poon E., and Davies K. The dystrophin associated protein complex. J. Cell Sci. 115 (2002) 2801-2803
15. Ross M.H., Kaye G.I., and Pawlina W. Histology a Text and Atlas with Cell and Molecular Biology (2003), Lippincott Williams & Wilkins, Baltimore p. 254
16. Honeyman K., Carville K.S., Howell J.M., Fletcher S., and Wilton S.D. Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele. AJVR 60 (1999) 734-737
17. González F.H.D., Carvalho V., Möller V.A., and Duarte F.R. Perfil bioquímico sanguíneo de cães e gatos na cidade de Porto Alegre, Rio Grande do Sul, Brasil. Arq Fac Vet. UFRGS 29 (2001) 11-16
18. Nguyen F., Cherel Y., Guigand L., Goubault-Leroux I., and Wyers M. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies. J. Comp. Path 126 (2002) 100-108
19. Evans J., Levesque D., and Shelton G.D. Canine inflammatory myopathies: aclinicopathologic review of 200 cases. J. Vet. Intern. Med. 18 (2004) 679-691
20. Neumann S. Serum creatine kinase activity in dogs and cats with metabolicdiseases. Dtsch Tierarztl Wochenschr. 112 (2005) 343-347
21. Martínez-Amat A., Boulaiz H., Prados J., Marchal J.A., Padial Puche P., Caba O., Rodríguez-Serrano F., and Aránega A. Release of a-actin into serum after skeletal muscle damage. Br. J. Sports Méd. 39 (2005) 830-834
22. Raphael J., Rivo J., and Gozal Y. Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/Akt signaling. Br. J. Anaesth. 95 (2005) 756-763
23. Sharp N.J.H., Kornegay J.N., Van Camp S.D., Herbstreith M.H., Secore S.L., Kettle S., Hung W.Y., Constantinou C.D., Dykstra M.J., Roses A.D., and Bartlett R.J. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13 (1992) 115-121
24. Saiki R.K., Gelfand D.H., Stoffel S., Scharf S.J., Higuchi R., Horn G.T., Mullis K.B., and Ehrlich H.A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239 (1988) 487-491
25. Koenig M., Monaco A.P., and Kunkel L.M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53 (1988) 219-228
26. Shalet S.M., Toogood A., Rahim A., and Brennan B.M.D. The diagnosis of growth hormone deficiency in children and adults. Endocr. Rev. 19 (1998) 203-223
27. Coutant R., De Casson F.B., Rouleau S., Douay O., Mathieu E., Gatelais F., Bouhours-Nouet N., Voinot C., Audran M., and Limal J.M. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents. J. Clin. Endoc. Metabol. 89 (2004) 6185-6192
28. Delafontaine P., Lou H., Harrison D.G., and Bernstein K.E. Sequence of a cDNA encoding dog insulin-like growth factor I. Gene 130 (1993) 305-306
29. Gundersen H.J.G. Notes of the estimation of the numerical density of arbitrary profiles: the edge effect. J. Microsc. 111 (1977) 219-223
30. Howard V., Reid S., Baddeley A., and Boyde A. Unbiased estimation of particle density in the tandem scanning reflected light microscope. J. Microsc. 138 (1985) 203-212
31. Gundersen H.J.G., Jensen E.B.V., Kieu K., and Jensen J. The efficiency of systematic sampling in stereology-reconsidered. J. Microsc. 193 (1999) 199-211
32. Nyengaard J.R. Stereologic methods and their application in kidney research. J. Am. Soc. Nephrol. 10 (1999) 1100-1123
33. MINITAB (v.14), Minitab Reference Manual, Florence, Wadsworth, 2006.
34. Statistical Analyses System. SAS User's Guide: Basic and Statistic. SAS, Cary, NC, 2005, p. 1686.
35. Evans H.E. Miller's Anatomy of the Dog. third ed. (1993), Saunders, Philadelphia
36. Dyce K.M., Sack W.O., and Wensing C.J.G. Textbook of Veterinary Anatomy. third ed. (2002), Springer, Philadelphia p. 210-211
37. Sasaki F. Changes with age in the number and size of anterior pituitary cells in female mice from suckling to adulthood. J. Endocr. 117 (1988) 5-10
38. Sasaki F., and Sano M. Role of the ovary in sexual differentiation of lactotrophs and somatotrophs in the mouse adenohypophysis: a stereological morphometric study by electron microscopy. J. Endocr. 99 (1983) 355-360
39. Baker B.L. Studies on hormone localization with emphasis on the hypophysis. J. Histoch. Cytoch. 18 (1970) 1-7
40. Anderson J.L., Head S.I., Rae C., and Morley J.W. Brain function in Duchenne muscular dystrophy. Brain 125 (2002) 4-13
41. Houzelstein D., Lyons G.E., Chamberlain J., and Buckingham M.E. Localization of dystrophin gene transcripts during mouse Embryogenesis. J. Cell Biol. 119 (1992) 811-821
42. Boquete H.R., Sobrado P.G.V., Fideleff H.L., Sequera A.M., Giaccio A.V., Suárez M.G., Ruibal G.F., and Miras M. Evaluation of diagnostic accuracy of insulin-like growth factor (IGF)-I and IGF-binding protein-3 in growth hormone-deficient children and adults using ROC plot analysis. J. Clin. Endocr. Metabol. 88 (2003) 4702-4708
43. Lissett C.A., Jönsson P., Monson J.P., and Shalet S.M. Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD. Clin. Endocr. 59 (2003) 773-778
44. Gomez J.M., Maravall F.J., Gomez N., Navarro M.A., Casamitjana R., and Soler R. The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Grow. Hormone IGF Res. 14 (2004) 91-96
45. Zatz M., and Frota-Pessoa O. suggestion for a possible mitigation treatment of duchenne muscular dystrophy. Am. J. Med. Genet. 10 (1981) 305-307
46. Zatz M., Betti R.T., and Frot-Pessoa O. Treatment of Duchenne muscular dystrophy with growth hormone inhibitors. Am. J. Med. Genet. 24 (1986) 549-566
47. Griggs R.C., Moxley R.T., Mendell J.R., Fenichel G.M., Brooke M.H., Miller P.J., Mandel S., Florence J., Schierbecker J., and Kaiser K.K. Randomized, double-blind trial of mazindol in Duchenne dystrophy. Muscle Nerve 13 (1990) 1169-1173
48. Coakley J.H., Moorcraft J., Hipkin L.J., Smith C.S., Griffiths R.D., and Edwards R.H. The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy. J. Neurol. Neurosurg. Psychiatr. 51 (1988) 1551-1557